Safety and efficacy of oral factor-Xa inhibitors versus Vitamin K antagonist in patients with non-valvular atrial fibrillation: Meta-analysis of phase II and III randomized controlled trials.
udgivet i: International Journal of Cardiology
dato for udgivelse: 2016-05-14
sprog: engelsk
main subject: phase II clinical trial, vitamin K, Fyllokinon, atrieflimren
Cites articles
There is nothing here
Artikel - wd:Q40730754